Key findings: I found that the drugs (Amprenavir, Indinavir, Lasofoxifene, Lopinavir, Nelfinavir, Raloxifene, Trifluoperazine, Ouabain) have high potential to inhibit the NSP3, and the drugs (Aprepitant, Lumiracoxib, Montelukast, Ritonavir, Sorafenib, Suvorexant) have high potential to inhibit the NSP12, drugs (Chlortetracycline, Dequalinium, Gemcitabine, Roflumilast, Sildenafil, Suvorexant, Citicoline, Vardenafil) have high potential to inhibit the main protease, all of these drugs could be utilised against SARS CoV 2. This study uses the pocket similarity as it's first filter which gives an association with the original target that the drug might do the same function on the predicted similar site. Add to this the unintentional discovery of 13 steroidal drugs that all have similar pockets on NSP12.